Trial Profile
Optimized EPO Treatment of Neonatal Anemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms OETNA
- 28 Apr 2021 Status changed from active, no longer recruiting to completed.
- 20 Feb 2019 Planned End Date changed from 1 Jun 2018 to 1 Dec 2019.
- 20 Feb 2019 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.